H6 code b20: the device remains implanted and was therefore not available for engineering evaluation.H6 code c20: a review of the manufacturing records for the device could not be conducted because the serial/lot number remains unknown.Without a lot number or device serial number, the manufacturing date and/or production details cannot be determined, and the information provided to gore cannot be connected to a specific device.Cbas® heparin surface incorporates carmeda heparin manufactured from heparin sodium api, which is covalently bound to the device surface and is essentially non-eluting.W.L.Gore & associates, inc.(gore) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by gore, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Blank fields present on this report include required fields and fields determined to be not applicable.Blank required fields indicate that the information was not provided, was deemed unavailable or was not applicable.This report does not constitute an admission or a conclusion by fda, gore, or its associates that the device, gore or its associates caused or contributed to the event described in the report.In particular, this report does not constitute a legal admission by anyone that the product described in this report has any defects or has malfunctioned, as defined from a legal standpoint.These words are included in the report and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.This statement should be included with any information or report disclosed to the public under the freedom of information act.
|
The following was reported to gore: on (b)(6) 2018, the patient underwent an evar procedure with bilateral ibe placement with large aneurysms in the abdominal aorta and both common iliac arteries (cia) measuring up to 14cm in max diameter.A gore® viabahn® vbx balloon expandable endoprosthesis (vbx device) was implanted in the right internal iliac artery as an extension for the ibe device.The sacs begin to shrink after the procedure.On (b)(6) 2023 imaging showed a stable abdominal aortic aneurysm (aaa) and left ciaa sac, but 3 mm increase in the right ciaa sac.There was an endoleak in the right cia/iia that appeared to be either type 1b vs 3 in nature.On (b)(6) 2024, an angiogram was performed and revealed a type 1b endoleak due to degeneration of the right internal artery around the distal end of the implanted vbx device.A reintervention was performed where embolization of the anterior branch and an additional vbx device was used into the posterior branch to extend the initial vbx device.The endoleak was excluded.The procedure was concluded without any other reported issue and patient tolerated the procedure.
|